Devinder Gill

Devinder Gill

UNVERIFIED PROFILE

Are you Devinder Gill?   Register this Author

Register author
Devinder Gill

Devinder Gill

Publications by authors named "Devinder Gill"

Are you Devinder Gill?   Register this Author

62Publications

1255Reads

18Profile Views

PI3K-p110δ contributes to antibody responses by macrophages in chronic lymphocytic leukemia.

Leukemia 2020 Feb 28;34(2):451-461. Epub 2019 Aug 28.

University of Queensland Diamantina Institute, Woolloongabba, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0556-zDOI Listing
February 2020

Diagnosis of fusion genes using targeted RNA sequencing.

Nat Commun 2019 03 27;10(1):1388. Epub 2019 Mar 27.

Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, 2010, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-019-09374-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437215PMC
March 2019

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

J Clin Oncol 2017 May 3;35(15):1678-1685. Epub 2017 Apr 3.

Kenneth F. Bradstock and Warwick Benson, Westmead Hospital, University of Sydney; Arno Enno, Sandra Deveridge, and Philip Rowlings, Calvary Mater Newcastle Hospital, Newcastle; Luke Coyle, Royal North Shore Hospital, St Leonards; Campbell Tiley, Central Coast Health, Gosford; John Moore, St Vincent's Hospital; Mark Hertzberg, Prince of Wales Hospital, Sydney; Kimberly Cartwright, Wollongong Hospital, Wollongong; Ilona Cunningham, Concord Repatriation General Hospital, Concord; John Taper, Nepean Hospital, Penrith, New South Wales; Emma Link, Juliana Di Iulio, and John F. Seymour, Peter MacCallum Cancer Centre; Jeff Szer, Andrew Grigg, Andrew W. Roberts, and John F. Seymour, University of Melbourne; Andrew H. Wei, Monash University; Anthony Schwarer, Box Hill Hospital; Lynda Campbell, Victorian Cancer Cytogenetics Service, Melbourne; Jeff Szer, Andrew Grigg, and Andrew W. Roberts, Royal Melbourne Hospital, Parkville; Phillip Campbell, Deakin University School of Medicine, Geelong, Victoria; Paula Marlton, Anthony K. Mills, and Devinder Gill, University of Queensland, Brisbane, Queensland; Ray M. Lowenthal, University of Tasmania, Hobart, Tasmania; Ian D. Lewis and Peter Bardy, Royal Adelaide Hospital; Uwe Hahn, Queen Elizabeth Hospital, Adelaide, South Australia; James D'Rozario, The Canberra Hospital, Garran, Canberra, Australia Capital Territory; Gavin Cull, Sir Charles Gairdner Hospital; Michael F. Leahy, University of Western Australia; and Paul Cannell, Royal Perth Hospital, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.6374
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.6374DOI Listing
May 2017

Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.

Nephrol Dial Transplant 2015 Oct 18;30(10):1774-9. Epub 2015 Jul 18.

Department of Haematology, Pathology Queensland and Cancer Services, Princess Alexandra Hospital, Brisbane, Australia School of Medicine, University of Queensland, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfv260DOI Listing
October 2015

Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.

Lancet Haematol 2015 Oct 1;2(10):e445-55. Epub 2015 Oct 1.

University of Queensland Diamantina Institute, Translational Research Institute, University of Queensland, Brisbane, QLD, Australia; Princess Alexandra Hospital, Brisbane, QLD, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(15)00150-7DOI Listing
October 2015

CD62L as a therapeutic target in chronic lymphocytic leukemia.

Clin Cancer Res 2013 Oct 15;19(20):5675-85. Epub 2013 Aug 15.

Authors' Affiliations: University of Queensland Diamantina Institute, Brisbane, Australia; Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia; Department of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, Florida; and Griffith Health Institute and School of Medical Sciences, Griffith University, Southport, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1037DOI Listing
October 2013

CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy.

Am J Hematol 2013 Apr 5;88(4):273-6. Epub 2013 Mar 5.

Queensland Institute of Medical Research, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23398
Publisher Site
http://dx.doi.org/10.1002/ajh.23398DOI Listing
April 2013

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.

Clin Cancer Res 2013 Feb 5;19(3):731-42. Epub 2012 Dec 5.

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research (QIMR), Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2693DOI Listing
February 2013

CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro.

Leuk Lymphoma 2012 Oct 19;53(10):1988-98. Epub 2012 Apr 19.

Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.672735DOI Listing
October 2012

WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation.

Leuk Res 2012 Apr 2;36(4):453-8. Epub 2011 Oct 2.

Department of Haematology, The Queen Elizabeth Hospital, Woodville South, SA, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.09.005DOI Listing
April 2012

Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.

Am J Hematol 2012 Mar 27;87(3):258-65. Epub 2011 Dec 27.

Clinical Immunohaematology Laboratory, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22252DOI Listing
March 2012

Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population.

Ann Hematol 2011 Mar 6;90(3):359-60. Epub 2010 Jul 6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-010-1023-0DOI Listing
March 2011

Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma.

Leuk Lymphoma 2010 Apr;51(4):641-9

Department of Clinical Haematology and Bone Marrow Transplantation, Royal Melbourne Hospital and University of Melbourne, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428191003611428DOI Listing
April 2010

Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation.

Clin Biochem Rev 2009 Aug;30(3):113-8

Haematology Department, Pathology Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754999PMC
August 2009

Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.

Am J Hematol 2008 Apr;83(4):330-3

Department of Clinical Hematology, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21062DOI Listing
April 2008

Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis.

Nat Clin Pract Oncol 2008 Apr 19;5(4):234-8. Epub 2008 Feb 19.

Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ncponc1071
Publisher Site
http://dx.doi.org/10.1038/ncponc1071DOI Listing
April 2008

Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.

Blood 2007 Aug 16;110(4):1326-9. Epub 2007 Apr 16.

Australian Centre for Vaccine Development, Tumor Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-01-066100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939905PMC
August 2007

Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases.

Clin Chim Acta 2007 Feb 14;376(1-2):30-6. Epub 2006 Jul 14.

Chemical Pathology Department, Queensland Health Pathology Service, Royal Brisbane and Princess Alexandra Hospitals, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2006.07.011DOI Listing
February 2007

Epstein-Barr virus T-cell immunity despite rituximab.

Br J Haematol 2007 Feb;136(4):628-32

EBV Biology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2006.06482.xDOI Listing
February 2007

MRI features of bone marrow necrosis.

AJR Am J Roentgenol 2007 Feb;188(2):509-14

Department of Radiology, Princess Alexandra Hospital, Ipswich Rd., Woolloongabba, Brisbane, Queensland 4102, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.05.0656DOI Listing
February 2007

Pharmaceutical impurities: regulatory perspective for Abbreviated New Drug Applications.

Adv Drug Deliv Rev 2007 Jan 15;59(1):64-72. Epub 2006 Nov 15.

Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2006.10.010DOI Listing
January 2007

Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients.

Blood 2006 Oct 6;108(7):2280-9. Epub 2006 Jun 6.

Tumor Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-04-015164DOI Listing
October 2006

Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.

Leuk Lymphoma 2006 Sep;47(9):1813-7

Department of Haematology, School of Medicine, University of Queensland, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane, Australia 4102.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600632832DOI Listing
September 2006

Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone marrow transplant.

J Rheumatol 2006 Apr;33(4):812-3

Department of Medicine, Royal Hobart Hospital, Hobart, Tasmania, Australia.

View Article

Download full-text PDF

Source
April 2006

Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.

Clin Cancer Res 2006 Jan;12(2):460-4

Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research, Department of Haematology, Princess Alexandra Hospital, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2008DOI Listing
January 2006

Role of VAD in the initial treatment of multiple myeloma.

Blood 2005 Nov;106(10):3674; author reply 3674-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-07-2610DOI Listing
November 2005

The reporting of serum protein electrophoresis to clinicians.

Clin Chim Acta 2005 Aug;358(1-2):204-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cccn.2005.04.010DOI Listing
August 2005

Induction with oral chemotherapy (CID) followed by early autologous stem cell transplantation for de novo multiple myeloma patients.

Hematol J 2004 ;5(3):216-21

Department of Clinical Haematology and Bone Marrow Transplantation, The Alfred Hospital, Melbourne, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.thj.6200342DOI Listing
September 2004

A rapid RT-PCR screening assay incorporating multiplexed validated control genes for CBF rearrangements at diagnosis in AML.

Pathology 2004 Aug;36(4):335-42

Queensland Health Pathology and Scientific Services, Department of Haematology, Princess Alexandra Hospital, Brisbane, Queensland 4101, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/0031302042000224593DOI Listing
August 2004

Determining virological, serological and immunological parameters of EBV infection in the development of PTLD.

Int Immunol 2004 Jul 24;16(7):983-9. Epub 2004 May 24.

Division of Immunology and Infectious Diseases and the Cooperative Research Centre for Vaccine Technology, The Queensland Institute of Medical Research and University of Queensland Joint Oncology Program, Brisbane, 4029 Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/intimm/dxh099DOI Listing
July 2004

Loss of PKR activity in chronic lymphocytic leukemia.

Int J Cancer 2004 Apr;109(3):329-35

Cancer Biology Programme, Centre for Immunology and Cancer Research, University of Queensland, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.11714DOI Listing
April 2004

Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs).

Adv Drug Deliv Rev 2004 Feb;56(3):397-414

Food and Drug Administration, Center for Drug Evaluation and Research, Metro Park North II, Room E204, Office of Generic Drugs, 7500 Standish Place, Rockville, MD 20855, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2003.10.011DOI Listing
February 2004

Practical considerations for the measurement of free light chains in serum.

Clin Chem 2003 Aug;49(8):1252-7

Chemical Pathology Department, Queensland Health Pathology Service, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/49.8.1252DOI Listing
August 2003

A single-centre experience of post-renal transplant lymphoproliferative disorder.

Transpl Int 2003 Jul 7;16(7):529-36. Epub 2003 May 7.

Department of Renal Medicine, Level 2, Ambulatory Renal and Transplant Services Building, University of Queensland, Princess Alexandra Hospital, Ipswich Road, QLD 4102, Woolloongabba, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00147-003-0596-0DOI Listing
July 2003